Arbutus Biopharma (ABUS) Stock Price & Analysis
ABUS$4.09+0.06 +1.49%
Market cap$626.97MEnterprise value$546.39MRevenue (TTM)$181.49MMarket position—
Score
81
Bullish
Value
64
Quality
79
Growth
100
AI Analysis
SnapshotArbutus Biopharma mixes growth with a still-reasonable multiple — Growth 100/100 with P/E 3.6. Under the hood: P/E 3.6, plus latest revenue up ~128% YoY.
Price History
Price: —
Fair value: —
—
P/E (TTM): —
Net Income (TTM): —
Score: —
—
Bullish (65+)Neutral (45–64)Bearish (<45)
Score Breakdown
Market percentile scores loading…
Value
64
PE Ratio (F)–
PEG Ratio–
Free Cashflow Yield %–
EV/EBITDA Ratio–
Discount vs All Time Peak–
Discount vs 1Y Peak–
Growth
100
Earnings Forecast–
Last 3M Earnings Growth %–
12M Revenue Growth %–
12M Earnings Growth %–
5 YR CAGR % Earnings–
Analyst Price Forecast–
Quality
79
FCF Margin %–
Net Debt / EBITDA–
Operating Margin %–
Operating Margin Growth %–
ROCE %–
Current Ratio–
Financial Summary
Arbutus Biopharma Corp (ABUS) last printed $4.09. Equity value is $626.97M. Trailing earnings multiple 2.85. The revenue row is reported history. Targets and ratings are on the forecast page.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| $1.5M | $10.7M | $5.9M | $6.01M | $6.91M | $10.99M | $39.02M | $18.14M | $6.17M | $14.08M |
About
Company description is not on file.